Navigation Links
Dendreon Reports Third Quarter 2007 Financial Results
Date:11/15/2007

lication (BLA) and support the

efficacy claim for PROVENGE.

-- Implemented a committed equity financing facility under which the

Company may sell up to $130 million of its registered common stock to

Azimuth Opportunity, Ltd. over an 18-month period. Dendreon is not

obligated to utilize any of the $130 million facility and remains free

to enter into and consummate other equity and debt financing

transactions.

-- Results from a Phase 1 study of NEUVENGE, an investigational active

cellular immunotherapy, were published in the August 20th issue of the

Journal of Clinical Oncology. The article highlighted the safety

profile, immune response and clinical activity of NEUVENGE in women

with HER2/neu-positive breast cancer who have failed standard therapy.

"We achieved an important milestone this quarter by completing enrollment of our Phase 3 IMPACT trial of PROVENGE, a therapy we believe has the potential to positively impact the lives of many prostate cancer patients who currently have few treatment options," said Mitchell H. Gold, M.D., president and chief executive officer of Dendreon. "We are grateful to the patients, clinical investigators and nurses who participated in this study. In addition, we would like to thank our vendors and suppliers, in particular the American Red Cross, Progenitor Cell Therapy and the Mayo Clinic, each of which provided high-quality, consistently excellent cell processing and service throughout the trial. We look forward to receiving interim results from this important study next year."

Conference Call Information

Dendreon will host a conference call today at 1:30 p.m. PT, 4:30 p.m. ET. To access the live call, dial 1-877-397-0235 (domestic) or +1 719-325-4876 (international). The call will also be audio webcast and will be available from the Company's website at http://www
'/>"/>

SOURCE Dendreon Corporation
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Dendreon Announces Webcast Presentation at UBS Life Sciences Conference
3. Dendreon Secures $130 Million Committed Equity Financing Facility
4. Dendreon Announces Webcast Presentations at Upcoming Investor Conferences
5. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
6. QMed, Inc. Reports July Medicare SNP Enrollments
7. Phlo Affiliate Reports Expanded Coverage to Oregon Border
8. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
9. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
10. Carrington Reports Second Quarter 2007 Results
11. Avitar Reports Third Quarter Financial Results for Fiscal 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... Tooth decay is an epidemic in American children with ... The World Health Organization says that worldwide, 60–90% ... What are the long-term effects of this transmissible infection? ... the oral bacterial imbalance and serious systemic issues like heart ... is also 100% preventable? Answer: there has been no way ...
(Date:5/16/2013)... (PRWEB) May 16, 2013 A ... portable models, from Cole-Parmer is designed to meet ... line includes: , The new Cole-Parmer® MS-3400 ... workhorses in the lab. They ensure a powerful ... plasma specimen separation. Their standard four-place swinging buckets ...
(Date:5/16/2013)... , May 16, 2013 Scientists at the ... Beijing , and the California ... demonstrated a novel therapy for reversing memory decline in ... they find significant cognitive improvement in advanced stage AD ... mechanism for reversing cognitive decline for advanced stage AD ...
(Date:5/16/2013)... VA (PRWEB) May 16, 2013 BioInformatics ... Primary Cells & Stem Cell-Derived Cells: Current and Future ... the number of suppliers in the primary cells market ... what cell types are used most often, how satisfied ... the market size and anticipated growth rate. , ...
Breaking Biology Technology:Seeing the Future: How a Revolutionary New Bacterial Screening Device Can Predict a Patient’s Future for Tooth Decay 2Seeing the Future: How a Revolutionary New Bacterial Screening Device Can Predict a Patient’s Future for Tooth Decay 3Cole-Parmer Offers Enhanced Selection of Centrifuges 2Elevation of Brain Magnesium Reverses Memory Deficits in Alzheimer Mice 2Elevation of Brain Magnesium Reverses Memory Deficits in Alzheimer Mice 3BioInformatics LLC New Market Report – The Market for Primary Cells & Stem Cell-Derived Cells: Current and Future Opportunities (13-004) 2BioInformatics LLC New Market Report – The Market for Primary Cells & Stem Cell-Derived Cells: Current and Future Opportunities (13-004) 3
... for the faint of heart. Global competition and offshore manufacturing ... with rising unemployment, the need to retrain workers, and a ... for new ways to survive and grow. , ,If ... Dr. Raj Veeramani, UW Professor of Engineering and Business and ...
... O'Malley, D.O. established his practice, O'Malley Family Medicine, ... that practicing ndependently would enable him to provide ... a solo practitioner build a thriving practice in ... essential," says O'Malley. "That's why I sought to ...
... of Wisconsin and Delta Dental Plan of New Jersey ... made by Aetna, Ameritas Life Insurance Corp., Delta Dental ... America, MetLife and Dental Benefit Providers (the dental subsidiary ... in a cooperative technology venture to enhance a platform ...
Cached Biology Technology:University Consortium Enables Transformation and Survival for Wisconsin Businesses 2University Consortium Enables Transformation and Survival for Wisconsin Businesses 3Computer Card Supports Solo Doctor 2
(Date:5/17/2013)... Researchers at Rutgers, The State University of New Jersey, ... proprietary new formulation called Visikol TM that effectively ... be used in place of chloral hydrate, which is ... but which is tightly regulated by the Drug Enforcement ... , Clearing solutions, or clearing agents, are vital for ...
(Date:5/17/2013)... 17, 2013, Shenzhen, China---- Why Tibetan antelope can ... Plateau? In a collaborative research published in ... and other institutes provide evidence that some genetic ... to harsh highland environments. The data in this ... genetic mechanisms and the biology of other ruminant ...
(Date:5/17/2013)... Societies for Experimental Biology (FASEB) released a new ... trends highlighting the devastating impact of sequestration on the ... follows a May 15th Senate Appropriations Committee hearing featuring ... the $1.6 billion cut the agency sustained in FY ... on the scientific community." , According to data ...
Breaking Biology News(10 mins):New formula invented for microscope viewing, substitutes for federally controlled drug 2New formula invented for microscope viewing, substitutes for federally controlled drug 3The genome sequence of Tibetan antelope sheds new light on high-altitude adaptation 2
... Berkeley -- Biologists have tracked down genes that control the ... similar to the genes used by humans to set up ... finding, reported online in advance of publication in Nature ... same genes have been responsible for establishing the left-right asymmetry ...
... Station (SRS) Fisheries Research Biologist Wendell Haag, Ph.D., received ... during a ceremony today at the White House. Haag ... the award, which is the highest honor that a ... States. The Presidential Early Career Award for ...
... 19, 2008 Researchers at UT Southwestern Medical Center have ... role in defending the lungs against invading pathogens is responsible ... older adults. The same mutation may also be associated with ... gene that UT Southwestern scientists have linked with idiopathic pulmonary ...
Cached Biology News:Snails and humans use same genes to tell right from left 2Snails and humans use same genes to tell right from left 3Snails and humans use same genes to tell right from left 4Haag honored with Presidential Early Career Scientists Award 2UT Southwestern researchers identify gene linked to inherited form of fatal lung disease 2UT Southwestern researchers identify gene linked to inherited form of fatal lung disease 3
... Eastman Kodak Companys Molecular Imaging ... KODAK Image Station 4000 Digital Imaging ... camera technology for comprehensive fluorescence, luminescence, ... systems 4 million pixel CCD and ...
Compound(s) tested through a broad panel of 38 ligand binding and enzyme assays targeting the Central Nervous System. Used to determine selectivity and potential GI liabilities of compounds....
... for the extraction of unwanted detergent ... macromolecules, Applications: ,Reducing octyl glucoside concentration ... of pure β-adrenergic receptor and pure ... in 6 M urea/0.05 mM Tris ...
... Proteolytic degradation is critical to ... short-lived and regulatory proteins as important ... cellular metabolism, heat shock and stress ... surface receptors and ion channels, cell ...
Biology Products: